Travere Therapeutics (TVTX) Total Debt (QoQ) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Travere Therapeutics | 4.14 Bn | 4.06 Bn | 102.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 0.12% |
| Mar 31, 2025 | 0.12% |
| Dec 31, 2024 | 0.12% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | -1.43% |
| Dec 31, 2022 | -4.11% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | -2.67% |
| Mar 31, 2022 | 1.35% |
| Mar 31, 2019 | 0.36% |
| Dec 31, 2018 | 0.36% |
| Sep 30, 2018 | -50.71% |
| Dec 31, 2017 | -22.00% |
| Sep 30, 2017 | -10.33% |
| Jun 30, 2017 | 6.04% |
| Mar 31, 2017 | -5.61% |
| Dec 31, 2016 | -22.51% |
| Sep 30, 2016 | -13.19% |
| Jun 30, 2016 | 36.33% |
| Mar 31, 2016 | -36.95% |
| Dec 31, 2015 | -7.86% |
| Sep 30, 2015 | -53.82% |
| Jun 30, 2015 | -12.47% |
| Mar 31, 2015 | 272.25% |
| Dec 31, 2014 | -52.27% |
| Sep 30, 2014 | 30.31% |